New Elite Feature: Screen & Chart at the same time

PROCEPT BioRobotics

Contributing Author

Recent Articles by PROCEPT BioRobotics

May-14	AUA Guidelines Strengthen Recommendation for Aquablation Therapy PRCT GlobeNewswire
Apr-30	PROCEPT BioRobotics to Attend Three Upcoming Investor Conferences in May & June PRCT +10.73% GlobeNewswire
Apr-29	PROCEPT BioRobotics Reports First Quarter 2026 Financial Results PRCT -5.73% GlobeNewswire
Apr-09	PROCEPT BioRobotics to Report First Quarter 2026 Financial Results on April 29, 2026 PRCT GlobeNewswire
Mar-23	EAU Guidelines Upgrade Aquablation Therapy to Strong Surgical Recommendation for BPH PRCT GlobeNewswire
Mar-12	PROCEPT BioRobotics Announces International Launch of the HYDROS Robotic System, Expanding Global Access to AI-Enabled Aquablation Therapy PRCT -6.04% GlobeNewswire
Feb-26	PROCEPT BioRobotics Hosts 2026 Investor Day to Detail Multi-year Financial Outlook and Strategic Plan for Long-Term Growth PRCT -15.12% GlobeNewswire
Feb-25	PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance PRCT GlobeNewswire
Feb-23	PROCEPT BioRobotics Announces Updated Dates for 4Q25 Earnings Conference Call and Investor Day PRCT GlobeNewswire
Feb-04	PROCEPT BioRobotics to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference PRCT -5.29% PRCT GlobeNewswire
Jan-26	PROCEPT BioRobotics to Host 4Q25 Earnings Conference Call on February 24, 2026, and Investor Day on February 25, 2026, in New York City PRCT GlobeNewswire
Nov-20	PROCEPT BioRobotics to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025 PRCT +7.06% PRCT GlobeNewswire
Nov-04	PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance PRCT -9.74% PRCT GlobeNewswire
Oct-15	PROCEPT BioRobotics to Report Third Quarter 2025 Financial Results on November 4, 2025 PRCT GlobeNewswire
Aug-06	PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance PRCT -13.35% PRCT -5.05% GlobeNewswire
Jul-24	PROCEPT BioRobotics President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO PRCT GlobeNewswire
Jul-23	Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation Therapy PRCT GlobeNewswire
Jul-21	PROCEPT BioRobotics to Report Second Quarter 2025 Financial Results on August 6, 2025 PRCT GlobeNewswire
Jul-14	Aquablation Therapy's Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule PRCT GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)